Reliance Pharma Fund Unrated

Value Research
Change from previous, NAV as on Sep 18, 2014
Category: Equity: Pharma
Assets: R 809 crore (As on Jun 30, 2014)
Expense: 2.64% (As on Mar 31, 2014)
Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Fund Managers
+ Sailesh Raj Bhan since Mar 2005